EXICURE, INC. Accumulated Other Comprehensive Income
EXICURE, INC. (XCUR) had Accumulated Other Comprehensive Income of -$2.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $102.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$2.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$2.00K 10-Q · filed 2026-05-29 |
| 2025-12-31 | -$2.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $102.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $101.00K 10-Q · filed 2025-08-08 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2023-12-31 | $0.00 10-K · filed 2024-06-06 |
| 2022-12-31 | $0.00 10-K · filed 2024-06-06 |
| 2022-09-30 | -$1.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$5.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$5.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$2.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | -$1.00K 10-Q · filed 2021-11-19 |
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $32.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $83.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $338.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$17.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$27.00K 10-K · filed 2021-03-11 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |